Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

Good Law
United States District Court, Northern District of CaliforniaMarch 16, 20204:17-cv-04405California727 words

Opinion

trial_court Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 PLEXXIKON INC., Case No. 17-cv-04405-HSG

8 Plaintiff, ORDER REGARDING MOTIONS TO

SEAL

9 v.

10 NOVARTIS PHARMACEUTICALS

CORPORATION,

11 Defendant. 12 13 The Court anticipates that, given the nature of this case, the parties will continue to file 14 voluminous or multiple administrative motions to seal. To streamline this process, the Court 15 directs the parties to review and comply with Civil Local Rule 79-5 as well as the Court’s 16 additional procedures as detailed below. 17 Any proposed order under Civil Local Rule 79-5(d)(1)(B) must include in the table for 18 each item sought to be sealed: (1) the docket numbers of the public and provisionally sealed 19 versions of documents sought to be filed under seal; (2) the name of the document; (3) the specific 20 portion(s) of the document sought to be filed under seal; and (4) the filer’s reasons for seeking 21 sealing of the material, along with citations to the relevant declarations and any supporting legal 22 authority. …

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.